Coca-Cola trades at 26 times forward earnings in a 5.3% interest rate regime, while facing an unreserved $14.9 billion IRS tax overhang. We initiate coverage with a Sell rating and a 12-month target of $77.00.
Key points
- 26.2 times forward comparable earnings leaves the shares stretched against historical staples valuations and a 5.3% Treasury rate.
- $14.9 billion in unreserved potential IRS transfer-pricing liabilities creates a $3.46 per share contingent cash claim.
- 22.0 times our 2027 comparable EPS estimate of $3.51 sets our 12-month target at $77.00, implying a 10% decline.
The call
The current $85.90 share price requires Coca-Cola to sustain a 26 times multiple while compounding earnings above historical rates. That pricing treats 2026 tailwinds from currency and World Cup marketing as structural acceleration, leaving virtually no margin of safety for input inflation or volume slowdowns. We believe the market is too optimistic on valuation durability.
Coca-Cola comparable EPS trajectory and forecastsReported 2023-2025 comparable EPS and 2026-2027 forecasts. Source: SEC filings and earnings releases.
We project 2027 comparable EPS of $3.51, representing 7% growth as foreign exchange tailwinds dissipate. With 10-year Treasury yields at 5.31%, Coca-Cola's 2.47% dividend yield sits 284 basis points below risk-free paper. Over the next twelve months, multiple compression toward historical norms of 22 times earnings should pull the stock lower.
Implied 12-month share price sensitivity to FY27E P/E multipleCoca-Cola 12-month target price across 2027E EPS multiples. Source: Desk research.
Valuation
| Valuation driver | Value |
|---|
| FY26E comparable EPS | $3.29 |
| FY27E comparable EPS | $3.51 |
| Target forward P/E multiple | 22.0x |
| Implied 12-month target price | $77.00 |
| Verified current price | $85.90 |
| Expected 12-month return | -10.4% |
A 22.0 times forward earnings multiple reflects high-single-digit organic growth offset by elevated capital costs and an unresolved $14.9 billion tax contingency. The asymmetry is negative, as modest mid-single-digit earnings growth cannot overcome four turns of multiple compression. We initiate coverage with a Sell rating.
Risks
- An appellate victory wiping out the IRS transfer-pricing liability would eliminate an overhang and drive an immediate cash refund.
- Sustained emerging-market volume reacceleration, especially in India and Latin America, could offset North American price elasticity.
- A steep decline in global interest rates could reignite bond-proxy demand for mega-cap defensive consumer staples.
What would change my mind
A full appellate exoneration on IRS transfer pricing paired with reaccelerating price/mix in Asia Pacific would invalidate our thesis.